Drug Pipeline

aripiprazole Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
4
Recruiting
1
Phase 3
4
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-27 NCT07483294
Cerebellum-based Imaging Neural Markers for Antipsychotic Response		 Phase changed: [] -> ['PHASE4']
2026-05-27 NCT07483294
Cerebellum-based Imaging Neural Markers for Antipsychotic Response		 Trial arms changed: 0 -> 1
Active Studies by Phase
Phase 4
2
Phase 3
1
Phase 1/2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06969755 Biomarkers to Enhance Early Schizophrenia Treatment Schizophenia Disorder Recruiting
NCT07483294 Cerebellum-based Imaging Neural Markers for Antipsychotic Response Psychosis; Acute Recruiting
Phase 3
NCT07565428 Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative… Negative Symptoms of Schizophrenia Recruiting
Phase 1/2
NCT05814640 Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) Depression Recruiting
Not specified
NCT06937476 Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole Major Depressive Disorder (MDD) Active, Not Recruiting
Sponsors Running aripiprazole Trials
Northwell Health (2) First Affiliated Hospital of Chongqing Medical University (1) Central South University (1) Minerva Neurosciences (1)
Disease Areas
Depression (2) Schizophrenia (1)
Get alerts when aripiprazole trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free